Subtype
Benign Reproductive System Neoplasm
CI-CAN-00000539Explore in graph →
Non-malignant53 active trials
- NCIt
- C7617
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000539Explore in graph →
Clinical trials
380 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01555073 | Preemptive Analgesia Following Uterine Artery Embolization | terminated | Phase 4 | 23 | Northwestern UniversityOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02819609 | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | completed | — | 12,234 | Quintiles, Inc.INDUSTRY | 0 | Jun 30, 2016 | clinicaltrials |
| NCT01675011 |
| Embozene Microspheres for Uterine Fibroid Embolization (UFE) |
| terminated |
| N/A |
| 4 |
| Boston Scientific CorporationINDUSTRY |
| 1 |
| Mar 11, 2016 |
| clinicaltrials |
| NCT02440750 | Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women | unknown | Phase 4 | 50 | University of CagliariOTHER | 0 | Mar 9, 2016 | clinicaltrials |
| NCT01156857 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIII) | completed | Phase 3 | 209 | PregLem SAINDUSTRY | 4 | Jan 15, 2016 | clinicaltrials |
| NCT01252069 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | completed | Phase 3 | 132 | PregLem SAINDUSTRY | 4 | Jan 13, 2016 | clinicaltrials |
| NCT02015806 | Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices(REMIND) | completed | N/A | 53,480 | Brigham and Women's HospitalOTHER | 1 | Jan 11, 2016 | clinicaltrials |
| NCT01642472 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLext2) | completed | Phase 3 | 64 | PregLem SAINDUSTRY | 4 | Jan 8, 2016 | clinicaltrials |
| NCT01588899 | China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids | completed | N/A | 107 | Philips HealthcareINDUSTRY | 1 | Oct 22, 2015 | clinicaltrials |
| NCT01229826 | Magnetic Resonance Elastography (MRE) of Uterine Fibroids(MRE) | completed | — | 134 | Mayo ClinicOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT01637974 | Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery | unknown | N/A | 130 | Carmel Medical CenterOTHER | 1 | Jul 31, 2015 | clinicaltrials |
| NCT02496442 | Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan | unknown | N/A | 30 | FlowmedINDUSTRY | 0 | Jul 14, 2015 | clinicaltrials |
| NCT01520441 | BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) | withdrawn | Early Phase 1 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT02086370 | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques(Rad_PBS) | completed | N/A | 177 | University Magna GraeciaOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01826617 | Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome | completed | — | 400 | St. Luke's Medical Center, PhilippinesOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT01886547 | 2013 Annual National Digital Rectal Exam (DRE) Day Study | completed | — | 925 | St. Luke's Medical Center, PhilippinesOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT01226290 | Fibroid Ablation Study(FAST-EU) | terminated | N/A | 51 | GynesonicsINDUSTRY | 3 | Apr 2, 2015 | clinicaltrials |
| NCT01539187 | Fibroid Ablation Study - Large Fibroids(FAST-L) | terminated | N/A | 6 | GynesonicsINDUSTRY | 3 | Mar 17, 2015 | clinicaltrials |
| NCT01998854 | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | terminated | — | 4 | GynesonicsINDUSTRY | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01635452 | A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids(PREMYA) | unknown | — | 1,500 | PregLem SAINDUSTRY | 10 | Jan 27, 2015 | clinicaltrials |
| NCT02049242 | Uterine Tourniquet at Open Myomectomy | completed | N/A | 48 | Ataturk UniversityOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02086279 | AMH Levels Change During Treatment With GnRh Agonist | completed | N/A | 67 | University Magna GraeciaOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02283502 | Clinical Test of the MRgHIFU System on Uterine Fibroids(MRgHIFU) | unknown | Phase 1 | 20 | Chin-Jung WangOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT00886873 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids(Mifemyo_2) | completed | Phase 2 / Phase 3 | 100 | Mediterranea Medica S. L.OTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT01177436 | Prostate Cancer Antigen 3 (PCA-3) Gene Project | completed | N/A | 31 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00702702 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 56 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00735553 | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 77 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00737282 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | terminated | Phase 3 | 175 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00785356 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 8 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00853567 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 71 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 27 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01678313 | Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels | completed | Phase 2 | 140 | Buddhist Tzu Chi General HospitalOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | withdrawn | Phase 3 | 0 | Repros Therapeutics Inc.INDUSTRY | 2 | Jun 27, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 0 | Apr 16, 2014 | clinicaltrials |
| NCT00822952 | Prostate Mechanical Imager (PMI) Clinical Bridging Study(PMI) | completed | — | 71 | Artann LaboratoriesINDUSTRY | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00485355 | Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy | completed | N/A | 27 | The Cleveland ClinicOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01203176 | Incidence of Malignant and Premalignant Endometrial Polyp in Asymptomatic and Symptomatic Postmenopausal Women | unknown | N/A | 1,400 | Arie Lissak, MDOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT00768742 | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study(FAST) | withdrawn | N/A | 0 | GynesonicsINDUSTRY | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01498237 | Photoacoustic Endoscopy in Endometrial Cancer | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Jul 11, 2013 | clinicaltrials |
| NCT01218243 | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia | completed | Phase 2 | 100 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | May 27, 2013 | clinicaltrials |
| NCT01452659 | Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids | completed | Phase 2 | 216 | TakedaINDUSTRY | 1 | Jan 21, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2016source: clinicaltrials